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A B S T R A C T   
Mitochondrial metabolism is increasingly implicated in psychopathologies and mood disorders, including post- 
traumatic stress disorder (PTSD). We recently reported that mice exposed to a novel paradigm for the induction 
of PTSD-like behavior displayed reduced mitochondrial electron transport chain (mtETC) complex activity as 
well as decreased multi-system fatty acid oxidation (FAO) flux. Based on these results, we hypothesized that 
stressed and PTSD-like animals would display evidence of metabolic reprogramming in both cerebellum and 
plasma consistent with increased energetic demand, mitochondrial metabolic reprogramming, and increased 
oxidative stress. 
We performed targeted metabolomics in both cerebellar tissue and plasma, as well as untargeted nuclear 
magnetic resonance (NMR) spectroscopy in the cerebellum of 6 PTSD-like and 7 resilient male mice as well as 7 
trauma-naïve controls. We identified numerous differences in amino acids and tricarboxylic acid (TCA) cycle 
metabolite concentrations in the cerebellum and plasma consistent with altered mitochondrial energy meta-
bolism in trauma exposed and PTSD-like animals. Pathway analysis identified metabolic pathways with signif-
icant metabolic pathway shifts associated with trauma exposure, including the tricarboxylic acid cycle, pyruvate, 
and branched-chain amino acid metabolism in both cerebellar tissue and plasma. Altered glutamine and 
glutamate metabolism, and arginine biosynthesis was evident uniquely in cerebellar tissue, while ketone body 
levels were modified in plasma. Importantly, we also identified several cerebellar metabolites (e.g. choline, 
adenosine diphosphate, beta-alanine, taurine, and myo-inositol) that were sufficient to discriminate PTSD-like 
from resilient animals. 
This multilevel analysis provides a comprehensive understanding of local and systemic metabolite fingerprints 
associated with PTSD-like behavior, and subsequently altered brain bioenergetics. Notably, several transformed 
metabolic pathways observed in the cerebellum were also reflected in plasma, connecting central and peripheral 
biosignatures of PTSD-like behavior. These preliminary findings could direct further mechanistic studies and 
offer insights into potential metabolic interventions, either pharmacological or dietary, to improve PTSD 
resilience.   
1. Introduction 
Post-traumatic stress disorder (PTSD) is a debilitating psychiatric 
disorder that precipitates following exposure to a traumatic event (TE), 
such as direct or repeated indirect exposure to death, injury, or sexual 
violence (Flory and Yehuda 2015). While lifetime incidence of TE 
exposure is high (64–70%) (Benjet et al., 2016), lifetime prevalence of 
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PTSD remains relatively low (1.3–12.2%) (Karam et al., 2014). Given 
this discrepancy between incidence of trauma exposure and PTSD pre-
cipitation, understanding the biologic factors involved with vulnera-
bility and resilience to PTSD should prove invaluable to developing 
improved prevention, diagnosis, and treatment of PTSD. 
Mitochondrial metabolism is increasingly implicated in several 
psychopathologies and neurodegenerative disorder, including Alz-
heimer’s, Parkinson’s, Huntington’s, bipolar disorder, anxiety, depres-
sion, and PTSD (Shao et al., 2008; Hollis et al., 2015; Pei and Wallace 
2018; Morava and Kozicz 2013; Preston et al. 2018). Mitochondria play 
a central role in several biological functions involved in PTSD psycho-
pathology, including synaptic plasticity, neurogenesis, apoptosis, and 
largescale brain network activation (Preston et al. 2018). Mitochondrial 
DNA variants have been associated with PTSD in humans (Flaquer et al., 
2015), and reduced mtDNA copy number has been observed in periph-
eral blood cells of combat veterans with PTSD (Bersani et al., 2016). 
Altered expression of mitochondrial genes have been identified in the 
brains of stressed humans and rodents (Han et al. 2013; Zhang et al., 
2015), and alterations in mitochondrial physiology, energy metabolism, 
and ATP production has been observed in stressed rodents (Xing et al., 
2013; Xiao et al. 2009; Xiao et al., 2011; Li et al., 2010; Wan et al., 2016; 
Han et al. 2013). However, the role of mitochondria in trauma response 
and PTSD pathophysiology has not been fully elucidated. 
The cerebellum is an emerging region of interest in susceptibility to 
psychopathology, including PTSD (Holmes et al., 2018; Rabellino et al., 
2018; Baldaçara et al., 2012), and has recently been implicated in 
vulnerability to psychopathology generally (Hariri 2019). We recently 
reported (Preston et al., 2020) reduced mtETC complex activity in the 
cerebellum and skeletal muscle, and evidence of reduced FAO oxidation 
flux in both the cerebellum and circulating plasma of mice exposed to a 
recently-developed paradigm of PTSD-induction (Lebow et al., 2012). 
This paradigm precipitated a robust and clinically-relevant PTSD-like 
behavioral phenotype in 12.5% of exposed animals, a comparable rate to 
PTSD incidence in humans exposed to a TE (Karam et al., 2014). 
Reduced mtETC complex activity in the cerebellar tissue of these ani-
mals directly correlated with PTSD-like behavioral symptom score. 
Animals exposed to the paradigm also displayed reduced mtDNA copy 
number in cerebellar tissue and peripheral blood cells, as well as 
reduced circulating carnitine. These data point to cerebellar and 
multi-stem alterations in mitochondrial physiology and metabolism in 
this animal model of PTSD. 
Patients with inherited mtETC complex deficiencies display a wide 
range of metabolic changes consistent with mitochondrial energy 
metabolic remodeling, including elevated lactic acid, altered TCA cycle 
metabolites, elevated ketones, and biomarkers for oxidative stress 
(Thompson Legault et al., 2015). We hypothesized that stressed animals 
will display metabolic remodeling consistent with increased energetic 
demand and mitochondrial metabolic reprogramming in both cere-
bellum and plasma, including evidence of altered bioenergetics, and 
increased oxidative stress relative to stress-naïve animals, and that these 
metabolic differences will be associated with PTSD-like symptom-
atology. Conversely, we hypothesized that PTSD-resilient animals will 
display metabolic changes consistent with active metabolic adaptation, 
including increased energy recruitment and oxidative stress buffering. 
We performed targeted metabolomics to assay for amino acids and TCA 
cycle metabolites in both cerebellum and plasma. We also performed 
untargeted nuclear magnetic resonance (NMR) for metabolites in the 
cerebellum, and targeted metabolomics for mitochondrial-specific me-
tabolites in plasma. Consistent with our hypothesis, stressed animals 
displayed changes consistent with metabolic reprogramming and 
increased oxidative stress, as well as altered mitochondrial phospholipid 
and arginine metabolism in the cerebellum, as well as evidence of 
increased energetic demand and decreased energy production in the 
plasma. Additionally, metabolites associated with reduced cerebellar 
energy metabolism and increased oxidative stress were identified as 
discriminative of PTSD-like and resilient animals. 
2. Methods and materials 
2.1. Animal background and maintenance 
Animals were housed four-to-a-cage in ventilated microisolator 
cages on a 12-h light/dark cycle in a pathogen free, temperature- 
controlled animal housing facility, with food and water ad libitum. 
FVB.129P2 mice, a strain of “sighted” FVB mouse wildtype for the Pde6b 
retinal degeneration allele, were acquired from The Jackson Laboratory. 
Abbreviations 
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2.2. PTSD induction and behavioral assessment 
48 male FVB.129P2 mice were exposed to the PTSD induction 
paradigm published by Lebow et al.20. PTSD was induced through two 
decontextualized sessions of inescapable electric foot shock over two 
consecutive days (Figs. S1A and B). Animals were assessed for risk 
assessment, marble burying, %pre-pulse inhibition, latency to peak 
startle amplitude, and light phase activity (Fig. S1A). 6 PTSD-like and 7 
resilient animals were identified based on performance in these behav-
ioral measures using a scoring and inclusion criteria (Fig. S1C). All an-
imal experiments were carried out in accordance with the National 
Institutes of Health guide for the care and use of Laboratory animals, and 
the Tulane University Institutional Animal Care and Use Committee. All 
efforts were made to minimize animal suffering, to reduce the number of 
animals used, and to utilize alternatives to in vivo techniques, if avail-
able. See Supplementary Methods for the detailed PTSD induction pro-
tocol. The results of the behavioral assessment for this cohort of animals 
have been previously published (Preston et al., 2020). It is well docu-
mented that the incidence of PTSD is significantly higher in female pa-
tients than in male patients (Kessler et al., 1995). However, the 
PTSD-induction paradigm used in this study has not yet been used to 
assess female mice. We therefore restricted our study to male mice. 
Further development of this paradigm will be required to validate its use 
in female animals. 
2.3. Sacrifice and necropsy 
All animals were sacrificed via live decapitation without the use of 
anesthetic. Trunk blood was collected with EDTA and centrifuged at 
10,000 RCF for 10 min, plasma was collected and flash frozen. The brain 
was removed and dissected coronally, separating the cerebellum from 
the forebrain and the cerebellum was flash frozen. 
2.4. Metabolomics analysis 
Metabolomics analysis was performed by the Mayo Clinic Metab-
olomics Core, Rochester MN (Wilkins et al., 2019). Amino acids in 
cerebellar tissue and plasma were separated on a Waters BEH C18 col-
umn (2.1 mm × 150 mm × 1.7 μm) and analyzed using Thermo TSQ 
Quantum Ultra mass spectrometer (West Palm Beach, FL) coupled with a 
Waters ACQUITY ultra performance liquid chromatography (UPLC) 
system. TCA cycle metabolites in cerebellar tissue were separated on an 
Agilent DB-5MS column (30 m × 0.25 mm × 0.25 μm) and detected with 
an Agilent 5977A gas chromatography/mass spectrometry (GC/MS) 
under electron impact and single ion monitoring conditions in positive 
mode. Untargeted NMR spectrometry was performed in cerebellar tissue 
using a Bruker AVANCE III 600 MHz NMR spectrometer (Bruker, Bill-
erica, USA). Mitochondria-specific metabolites in plasma were run by 
GC/MS with: HP-5 (Cross linked 5% phenylmethyl silicone), (25m; ID 
0.20 mm; film thickness 0.33 μm) on Agilent 7890B Gas Chromatog-
raph/Mass Spectrometer (GC/MS) Agilent 7693 Autosampler, with 
Agilent Masshunter Acquisition 10.0.368. All metabolite abundances 
were normalized to total metabolite abundance in each sample. 
2.5. Statistical analyses 
All statistical analyses were performed using GraphPad Prism or 
SPSS. Student’s T-test was used to compare two groups, with false dis-
covery rate set to 10%. Data are expressed as averages ± standard de-
viation. Linear discriminant analysis (LDA) was performed using SPSS. 
Principal component analysis (PCA) and pathway analysis was per-
formed using Metaboanalyst 4.0 (Chong et al. 2019). For comparisons, 
the 6 identified PTSD-like animals were compared to the 7 identified 
resilient (trauma-exposed control) animals. To assess the impact of 
trauma exposure the combined group of PTSD-like and resilient 
(stressed) animals were compared to 7 animals not exposed to trauma 
(naïve). 
3. Results 
3.1. Cerebellar amino acids and TCA cycle metabolites 
Stressed animals displayed elevated abundance of beta-alanine (B- 
Ala), ethanolamine (Etn), gamma-aminobutyric acid (GABA), and L- 
cystine (Cys), and reduced abundance of L-citrulline (Cit) and L-valine 
(Val) (Fig. 1A, C). Stressed animals also displayed reduced ratios of L- 
glutamate (Glu):GABA (Fig. 1D), phosophoethanolamine (PEtn):Etn 
(Fig. 1E), and reduced ratios of Cit:L-arginine (Arg) and L-ornithine 
(Orn):Arg (Fig. 1F). With regard to TCA cycle metabolites we found that 
stressed animals displayed reduced abundance of succinate and Glu 
(Fig. 1F, I). Notably, while the abundances of several cerebellar amino 
acids and TCA cycle metabolites were significantly altered in stressed 
animals relative to naïve animals, no metabolite abundance varied 
significantly between PTSD-like and resilient animals (Fig. 1B, H). 
3.2. Cerebellar untargeted NMR 
Untargeted NMR identified numerous metabolic changes in the 
cerebella of stressed animals. Stressed animals displayed reduced 
abundances of glycerophosphocholine (GPC), inosine mono-phosphate 
(IMP), adenosine monophosphate (AMP), and adenosine diphosphate 
(ADP), and elevated abundance of lactate, L-glycine (Gly), L-aspartate 
(Asp), acetate, inosine, hypoxanthine (HPX), choline (Cho), and GABA 
(Fig. 2A, C). As in the amino acid panel, stressed animals displayed 
reduced ratios of Glu:GABA (Fig. 2D). 
Stressed animals displayed reduced ratios of IMP:HPX (Fig. 2E), 
phosphocholine (PCho):Cho, and GPC:PCho (Fig. 2F). Again, while no 
single metabolite abundance varied significantly between PTSD-like and 
resilient animals (Fig. 2B), PTSD-like animals displayed reduced PCho: 
Cho relative to PTSD-resilient animals (Fig. 2G). 
3.3. Plasma amino acids and mitochondrial metabolites 
Stressed animals displayed numerous changes in circulating amino 
acids, including elevated abundance of Gly, and L-cystathionine, and 
reduced abundance of Val, L-methionine (Met), alpha-aminoadipic acid 
(AAA), L-leucine (Leu), and L-isoleucine (Ile) (Fig. 3A, C). 
Stressed animals displayed elevated abundance of 3-methylgluta-
conic acid (MGA), 2-ketobutyric acid (aKB), citric acid, fumaric acid, 
2-ketoisocaproic acid (aKIC), 2-ketoisovaleric acid (aKIV), malic acid, 
succinic acid, 3-hydroxybutyric Acid (BHB), 3-methyl-2-ketovaleric acid 
(BMaKV), acetoacetic acid (AcAc), and 2-hydroxybutyric acid (aHB), 
and slightly reduced abundance of lactic acid (Fig. 4A, C). Stressed an-
imals also displayed elevated total abundance of plasma TCA metabo-
lites, which has been observed in congenital mtETC dysfunction 
(Fig. 4D). It is notable that stressed animals displayed significantly 
altered abundances of almost all metabolites measured in the targeted 
mitochondrial metabolite panel, suggesting profound, mitochondrial 
metabolic reprogramming with exposure to trauma. Again, however, 
PTSD-like animals displayed no significant changes in any single plasma 
metabolite relative to resilient animals (Figs. 3B and 4B). 
3.4. Linear discriminate analysis (LDA) 
Given the large number of metabolites altered in stressed animals 
relative to naïve animals, and the near absence of individual metabolites 
varying between PTSD-like and resilient animals, linear discriminant 
analysis (LDA) was performed to determine which populations of me-
tabolites, if any, would be able to discriminate stressed and naïve, and 
PTSD-like and resilient animals. LDA identified GABA, Val, Orn, HPX, 
and Ile abundance as primary discriminators of stress-naïve and stressed 
animals in the cerebellum (Fig. 5A, Table 1), and citric acid, Ile, B-Ala, 
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and cis-aconitic acid abundance as primary discriminators of stress- 
naïve and stressed animals in plasma (Fig. 5B, Table 1). 
LDA identified Cho, ADP, B-Ala, taurine, and myo-inositol abun-
dance as primary discriminators of PTSD-vulnerable and –resilient ani-
mals in the cerebellum (Fig. 5C, Table 1). No factors able to discriminate 
PTSD-resilient and –vulnerable animals were identified in plasma. 
Notably, primary discriminators of both stress-naïve and stressed, as 
well as PTSD-like and resilient animals identified in the cerebellum were 
able to correctly identify group membership in 100% of animals 
analyzed. 
Also notably, the primary discriminator of PTSD-like and resilient 
animals identified in this study, cerebellar choline abundance, directly 
correlated with the PTSD-symptom score used to identify PTSD-like and 
resilient animals (Fig. S1A), and inversely correlated with two powerful 
predictors of PTSD-like behavior identified in a previous study of these 
animals (Preston et al., 2020), the activities of cerebellar mitochondrial 
complex I (Fig. S2B) and complex IV (Fig. S2C). Cerebellar choline 
abundance did not significantly correlate with the activity of succinate: 
cytochrome c oxidase (SCC) activity, a third predictor of PTSD-like ac-
tivity identified in a previous study (Preston et al., 2020). 
3.5. Pathway analysis 
Metaboanalyst 4.0 identified eleven pathways showing a significant 
number (FDR p < 0.05) of affected cerebellar metabolites in stressed 
animals relative to naïve animals: aminoacyl-tRNA biosynthesis; 
alanine, aspartate and glutamate metabolism; glyoxylate and dicar-
boxylate metabolism; arginine biosynthesis; citrate cycle (TCA cycle); 
histidine metabolism; beta-alanine metabolism; glycine, serine, and 
threonine metabolism; pyruvate metabolism; glutamine and glutamate 
metabolism; and valine, leucine, and isoleucine biosynthesis (Table 2). 
Alternately, Metaboanalyst 4.0 identified eight pathways showing a 
significant number of affected plasma metabolites in stressed animals 
relative to naïve animals: glyoxylate and dicarboxylate metabolism; 
valine, leucine, and isoleucine biosynthesis; glycine, serine and threo-
nine metabolism; synthesis and degradation of ketone bodies; Citrate 
cycle (TCA cycle); pyruvate metabolism; aminoacyl-tRNA biosynthesis; 
and alanine, aspartate and glutamate metabolism (Table 1). An insuf-
ficient number of metabolites varying significantly between PTSD-like 
and resilient animals were identified to perform pathway analysis. 
Principle component analysis (PCA) identified cystine, butyr-
ylcarnitine (C4) and glycine as the principle metabolites associated with 
trauma exposure in the cerebellum (Fig. 5D), while ascorbate and 
choline were identified as the principle metabolites associated with 
PTSD-like behavior in the cerebellum (Fig. 5E). In plasma, PCA identi-
fied 1-methylhistidine as the principle metabolite associated with both 
trauma exposure, as well as PTSD-like behavior (Fig. 5F and G). 
4. Discussion 
The field of metabolomics continues to improve our understanding of 
the pathology of numerous disease states, including inborn errors of 
metabolism, acquired metabolic dysfunction, and even psychiatric dis-
orders (Tebani et al., 2016; Klein and Shearer, 2016; Kawamura et al., 
2018).Understanding the diverse metabolic changes associated with a 
disease state can provide valuable insights into avenues of diagnosis, 
Fig. 1. Cerebellar amino acids and tricarboxylic acid (TCA) cycle metabolites. A,B,G,H. Heat maps represent median amino acid and TCA cycle concentration Z 
values in stressed and naïve (A,G) and PTSD-like and resilient (B,H) mice. C,I. Relative concentrations of significant cerebellar amino acid (C) and TCA cycle (I) 
metabolite changes in stressed animals relative to naïve animals. D. Relative ratio of cerebellar gamma-aminobutyric acid (GABA):glutamate (Glu) in stressed and 
naïve mice. E. Relative ratio of cerebellar phosphoethanolamine (PEtn):ethanolamine (Etn) in stressed and naïve mice. F. Relative ratios of cerebellar urea and nitric 
oxide cycle metabolites in stressed and naïve mice. p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), p < 0.0001 (****). 
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Fig. 2. Cerebellar metabolites identified through nuclear magnetic resonance (NMR) spectroscopy. A,B. Heat maps represent median cerebellar metabolite con-
centration Z values in stressed and naïve (A) and PTSD-like and resilient (B) mice. C. Relative concentrations of cerebellar NMR metabolites in stressed animals 
relative to naïve animals. D. Relative ratio of cerebellar gamma-aminobutyric acid (GABA):glutamate (Glu) in stressed and naïve mice. E. Relative ratios of cerebellar 
inosine monophosphate (IMP):hypoxanthine (HPX) and adenosine diphosphate (ADP):adenosine monophosphate (AMP). F,G. Relative ratios of cerebellar phos-
phocholine (PCho):choline (Cho) and glycerophosphocholine (GPC):phosphocholine (PCho) in stressed and naïve (F) and PTSD-like and resilient (G) mice. p < 0.05 
(*), p < 0.01 (**), p < 0.001 (***), p < 0.0001 (****). 
Fig. 3. Plasma amino acids. A,B. Heat maps represent median plasma metabolite concentration Z values in stressed and naïve (A) and PTSD-like and resilient (B) 
mice. C. Relative concentrations of cerebellar amino acid changes in stressed animals relative to naïve animals. p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), p <
0.0001 (****). 
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prevention, and treatment, and is indispensable to the emerging field of 
personalized medicine (Chan and Ginsburg 2011). Recent metabolomic 
studies have elucidated the metabolic pathologies of both primary 
mitochondrial disease (Thompson Legault et al., 2015) as well as PTSD 
(Mellon et al., 2019). We recently reported stress-induced mitochondrial 
electron transport chain and fatty acid oxidation alterations in the 
cerebellar tissue of mice displaying PTSD-like behavior, as well as evi-
dence of multisystem fatty acid oxidation changes. Here, we report ev-
idence of profound metabolic rewiring in animals exposed to trauma 
capable of precipitating PTSD-like behavior, and metabolic bio-
signatures discriminating PTSD-like and resilient animals. 
We hypothesized that stressed animals would display metabolic 
changes consistent with altered mitochondrial energy metabolism in the 
cerebellum. Consistent with our hypothesis, stressed animals displayed 
reduced abundances of cerebellar ADP and AMP, and elevated abun-
dances of IMP and HPX, measured by NMR spectroscopy. ATP rapidly 
degrades to ADP and is rarely detected by NMR. Hence we were unable 
to measure ATP in this study. Elevated HPX, which significantly corre-
lated with reduced AMP, was identified by LDA as a discriminator of 
stressed from naïve animals in the cerebellum. Stressed animals also 
displayed significantly decreased abundances of the phosphorylated 
metabolites IMP, PCho, and PEtn relative to their precursors HPX, Cho, 
and Etn, respectively. These metabolic alterations are consistent with 
reduced cerebellar ATP and, along with the elevated lactate, corroborate 
the reduced mtETC complex activity previously reported in these tissues 
(Preston et al., 2020). In addition, ADP was identified by LDA as a pri-
mary discriminator of PTSD-like from resilient animals. PTSD-like ani-
mals also displayed reduced cerebellar PCho:Cho relative to resilient 
animals. 
Stressed animals also displayed elevated cerebellar GABA in both 
amino acids and NMR, and LDA identified GABA as the primary 
discriminator of stress-naïve and stressed animals. GABA is the primary 
inhibitory neurotransmitter in the brain, and has been shown to be 
elevated in the rat cerebellum in response chronic stress (Kazi and 
Oommen 2014). Stressed animals also displayed an elevated ratio of 
GABA:Glu, the primary excitatory neurotransmitter in the brain, indi-
cating a reprogramming of cerebellar excitation and inhibition associ-
ated with trauma exposure. Pathway analysis identified a significant 
number of metabolites altered in the glutamate and glutamine pathways 
between stressed and naïve animals. Reduced GABA has been identified 
in cortical regions of both chronically stressed rats (Kazi and Oommen 
2014), as well as patients both exposed to trauma (Sheth et al., 2019) 
and those suffering from PTSD (Meyerhoff et al., 2014). Altered GABA: 
Glu has also been implicated in the pathophysiology of psychopathol-
ogies including major depressive disorder and schizophrenia (Liriano 
et al. 2019; Chen et al., 2017). This study suggests that reduced GABA: 
Glu balance in the cerebellum may contribute to PTSD-like behavior in 
mice. 
Significant cerebellar metabolic changes associated with phospho-
lipid metabolism were also observed in stressed and PTSD-like animals. 
Stressed animals displayed elevated abundances of Cho and GPC. In 
addition to the previously mentioned reduced PCho:Cho, stressed ani-
mals also displayed reduced GPC:PCho, suggesting a disruption in the 
PC synthesis pathway. LDA identified Cho as the primary discriminator 
of PTSD-like and resilient animals. As previously stated, stressed animals 
also displayed reduced cerebellar PEtn:Etn, and Cho and Etn were highly 
significantly correlated in this cohort. Etn and Cho are precursors of 
phosphatidylethanolamine (PE) and phosphatidylcholine (PC), respec-
tively (Farine et al., 2015), the two most abundant phospholipid species 
in biologic membranes. The first step in the PE and PC synthesis path-
ways is the ATP-dependent phosphorylation of the precursors Etn and 
Cho to PEtn and PCho, respectively. Recent studies have identified 
altered phospholipid metabolism associated with diminished mito-
chondrial energy metabolism in the brains of patients with psychopa-
thologies like depression and bipolar disorder (Modica-Napolitano and 
Renshaw 2004), and increased phospholipid damage and subsequent 
turnover has been reported following inhibition of the mtETC in vitro 
(Farber et al. 2000). Conversely, both altered mitochondrial phospho-
lipid composition as well as increased abundances of phospholipid 
precursors have been observed to alter mitochondrial function (Mod-
ica-Napolitano and Renshaw 2004; Rubin and Rottenberg 1982), sug-
gesting the possibility of a feed-forward interaction between mtETC and 
phospholipid metabolism. We have also previously reported a mtETC 
complex-I driven mitochondrial association between stress-exposure 
and PTSD-vulnerability in the cerebella of these animals, with reduced 
activity of both cerebellar complex I and complex IV being highly pre-
dictive of PTSD-like behavior (Preston et al., 2020). The abundance of 
cerebellar choline in these animals inversely correlated with activity of 
cerebellar complex I and complex IV (Figs. S2B and C). These data are 
consistent with a reduction of phospholipid synthesis pathway flux in 
Fig. 4. Plasma mitochondrial metabolite panel. A,B. Heat maps represent median plasma metabolite concentration Z values in stressed and naïve (A) and PTSD-like 
and resilient (B) mice. C. Relative concentrations of cerebellar mitochondrial metabolites in stressed animals relative to naïve animals. D. Total plasma tricarboxylic 
acid (TCA) cycle metabolite concentrations in naïve and stressed animals. p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), p < 0.0001 (****). 
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Fig. 5. Linear Discriminant Analysis and 
Principal Component Analysis of cerebellar 
and plasma metabolites. A,B,C. Histogram 
of metabolites discriminating stressed and 
naïve (A) and PTSD-like and resilient (C) 
animals in cerebellum, and metabolites 
discriminating stressed and naïve animals 
in plasma (B). Plot of metabolites identified 
by principal component analysis in cere-
bellum between stressed and naïve (D) and 
PTSD-like and resilient (E) animal, and in 
plasma between stressed and naïve (F) and 
PTSD-like and resilient (G) animals.   
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the cerebellum associated with reduced mtETC complex activity sec-
ondary to exposure to trauma and PTSD-like symptomatology. Unfor-
tunately, it was not possible to directly assay de novo phospholipid 
synthesis in the cerebellar tissues assayed in this study, and further 
studies will be required to directly confirm this metabolic alteration. 
Elevated B-alanine was identified by LDA as a discriminator of PTSD- 
like and resilient animals, and is a rate limiting precursor of both car-
nosine and anserine (Modica-Napolitano and Renshaw 2004; Artioli 
et al., 2010), intracellular antioxidants and membrane stabilizers in 
mouse muscle and brain (Kohen et al., 1988; Boldyrev et al., 1993). LDA 
also identified reduced cerebellar taurine, an important buffer of mito-
chondrial complex I-associated oxidative stress (Jong et al., 2017), as a 
discriminator of PTSD-like and resilient animals. Stressed animals also 
displayed elevated cerebellar cysteine and glycine, the precursors for 
glutathione (GSH), the primary antioxidant in mammals. Taken 
together, these metabolic data are consistent with increased oxidative 
stress and inner mitochondrial phospholipid membrane alterations in 
the cerebella of PTSD-like animals. 
Following the phospholipid and oxidative stress pathways, the most 
significant alterations between stress-naïve, PTSD-resilient and PTSD- 
like animals were associated with branched-chain amino acids 
(BCAA’s), particularly Val. Stressed animals displayed reduced pro-
portions of Val in the cerebellum, and reduced proportions of Val, Leu, 
and Ile, as well as their metabolic intermediates 2-ketoisocaproate, 2- 
ketoisovalerate, and 2-keto-3-methylvalerate in plasma. Reduced pro-
portions of both valine (which was significantly correlated with 
isoleucine) and isoleucine (which was significantly correlated with both 
valine and leucine) were identified as primary discriminators of stress- 
naïve and stressed animals in the cerebellum, and reduced proportions 
of Leu (which was significantly correlated with both Val and Ile) was 
identified as a discriminator of stress-naïve and stressed animals in 
plasma. BCAA’s are deaminated to keto acids, which are then able to 
supplement either acetyl-CoA or succinyl-CoA, and enhance flux 
through the TCA cycle (Kainulainen et al. 2013). Circulating valine can 
also be converted to BHB and then to AcAc, which are preferred sub-
strates for the brain. However, stressed animals also displayed elevated 
ratios of aKIV acid and MGA, two biomarkers for altered keto acid 
production in the liver. Elevated citrate, the primary discriminator of 
stressed animals, was significantly correlated with BHB, AcAc, aKIV, and 
MGA. These data together suggest an increased mobilization of BCAA’s 
and ketone bodies, and a concomitant multisystem reduction in mito-
chondrial oxidative phosphorylation. These data are consistent with the 
stress-induced multisystem fatty acid recruitment and concomitant fatty 
acid oxidation changes previously reported in these same animals. 
BCAA’s have also been shown to improve mitochondrial health by 
promoting mitochondrial biogenesis and reactive oxygen species buff-
ering (D’Antona et al., 2010). Increased demand for oxidative stress 
buffering is a significant metabolic feature of stress and 
PTSD-vulnerability in these animals. Reduced plasma isoleucine, which 
discriminated stressed animals, correlated with plasma methionine, 
which was reduced in stressed animals. Reduced plasma Met is a 
biomarker of increased demand for the GSH precursor Cys. Homocys-
teine is diverted away from Met synthesis toward synthesis of cys-
tathionine, which was elevated in stressed animals. Cleavage of 
cystathionine to cystine releases aKB, which is converted to aHB, both of 
which were elevated in stressed animals. 
One proposed mechanism by which BCAA’s promote mitochondrial 
biogenesis is by promoting the nitric oxide (NO) synthesis/urea cycle 
metabolic pathways (Valerio, D’Antona, and Nisoli 2011). Nitric oxide 
deficiencies are an important pathophysiologic feature of mitochondrial 
myopathy, encephalopathy, and lactic acidosis syndrome, one of the 
most common mitochondrial diseases in humans (El-Hattab et al. 2017), 
and urea cycle disorders have been linked to increased oxidative stress 
(Parmeggiani and Vargas 2018). Our data appear to implicate the 
overlapping urea cycle and NO synthesis pathways in the pathophysi-
ology of stress in these animals. In healthy cells, Cit is metabolized to 
Arg, which can then be broken down to urea and Orn, or NO and Cit. 
Elevated cerebellar ornithine was identified as a discriminator of 
stress-naïve and stressed animals, and stressed animals displayed a 
decreased cerebellar Cit, as well as increased ratios of Arg:Cit and Arg: 
Orn in the cerebellum. Consistent with this, pathway analysis identified 
a significant number of altered metabolites in the Arginine Biosynthesis 
pathway in the cerebella of stressed animals. NO synthesis from arginine 
takes place in the mitochondria, and decreased Cit and increased Arg:Cit 
in the cerebella of stressed animals may confirm the mitochondrial 
metabolic reprogramming previously reported (Preston et al., 2020). 
Additionally, these data suggest that ketogenic diet or exogenous ketone 
body supplementation may offer therapeutic potential for patients with 
Table 1 
Factors identified by linear discriminant analysis as discriminating stressed and 
naïve, and PTSD-like and resilient animals in cerebellum and plasma.  
Tissue Groups Discriminator Sign 















Metabolic pathways in cerebellum and plasma significantly affected by exposure 
to the PTSD-induction paradigm, including 10% false discovery rate (FDR) p 
values. Pathways in bold typeface were significantly altered in both cerebellum 
and plasma.  
Tissue Groups Pathway FDR p 
Cerebellum Naïve vs. 
Stressed 
Aminoacyl-tRNA biosynthesis 2.1E- 
12  
Alanine, aspartate and glutamate 
metabolism 
7.1E-8  
Glyoxylate and dicarboxylate 
metabolism 
3.8E-6  
Arginine biosynthesis 2.6E-5  
Citrate cycle (TCA) 2.3E-4  
Histidine Metabolism 8.9E-4  
Beta-Alanine metabolism 3.1E-3  
Glycine, serine and threonine 
metabolism 
3.1E-3  
Pyruvate metabolism 3.1E-3  
D-Glutamine and D-glutamate 
metabolism 
3.9E-3  
Valine, leucine, and isoleucine 
biosynthesis 
9.4E-3 
Plasma Naïve vs. 
Stressed 
Glyoxylate and dicarboxylate 
metabolism 
1.6E-3  
Valine, leucine and isoleucine 
biosynthesis 
3.0E-3  
Glycine, serine and threonine 
metabolism 
1.2E-2  




Citrate cycle (TCA cycle) 2.16E- 
2  
Pyruvate metabolism 2.16E- 
2  
Aminoacyl-tRNA biosynthesis 2.16E- 
2  




G. Preston et al.                                                                                                                                                                                                                                 
Neurobiology of Stress 14 (2021) 100300
9
PTSD. The ketone bodies acetoacetate (AcAc) and beta-hydroxybutyrate 
(BHB) are small molecules catabolized in the liver via fatty acid oxida-
tion during times of starvation or metabolic stress, when carbohydrates 
are scarce (Achanta and Rae 2017; Newman and Verdin 2014). Meta-
bolic shifts toward ketone body catalysis have been reported in patients 
with schizophrenia (Yang et al., 2013), and increasing circulating ke-
tones, through either ketogenic diets (Sussman et al. 2015; Phelps et al. 
2013; Kraeuter, van den Buuse, and Sarnyai 2019; Kraft and Westman 
2009; Palmer 2017; Palmer et al. 2019; Kraeuter et al., 2015; Murphy 
et al., 2004; Ahn et al., 2014; Evangeliou et al., 2003; Ruskin et al., 2017; 
Murphy and Burnham 2006) or exogenous ketone supplementation (Ari 
et al., 2016; Kashiwaya et al., 2013; Brownlow et al., 2017), have 
demonstrated therapeutic effects in psychiatric disease in both rodents 
and humans. AcAc and BHB freely cross the blood-brain barrier and 
enter the mitochondria, where they are converted to acetyl-CoA, driving 
ATP synthesis (Achanta and Rae 2017; Newman and Verdin 2014). 
Ketone bodies increase mitochondrial complex I-driven respiration, 
reducing reactive oxygen species production, attenuating oxidative 
stress, and improving brain energy metabolism (Maalouf et al., 2007; 
VanItallie and Nufert 2003; Sato et al., 1995). Additionally, ketones 
have been shown to decrease neuron hyper-excitability, and modulate 
GABA:Glu neurotransmitter balance (Achanta and Rae 2017; McNally 
and Hartman 2012), making ketone supplementation a promising po-
tential treatment for PTSD-like symptomatology. Ketogenesis requires 
acetyl-CoA produced through hepatic mitochondrial fatty acid oxidation 
(FAO), and we have previously reported evidence of reduced flux 
through the hepatic FAO pathway in the animals reported on in this 
study (Preston et al., 2020). As such, supplementation with exogenous 
ketones, such as ketone salts, may ultimately prove preferable to keto-
genic diet in the treatment of PTSD-like symptomatology. 
Consistent with our hypothesis, these data reveal significant meta-
bolic shifts associated with exposure to stress, as well as PTSD-like 
behavior in these animals. Pathway analysis identified eleven path-
ways with a significant number of altered metabolite species in the 
cerebella of animals exposed to trauma. These data shed new light on the 
role of the cerebellum, and emerging area of interesting in human 
cognition, in the pathophysiology of stress response and trauma 
vulnerability/resilience. As hypothesized, the metabolic shifts observed 
in stressed animals were highly associated with mitochondrial function. 
In addition to cerebellar metabolic shifts, the evidence of multisystem 
mitochondrial alteration is notable. Research into traumatic event 
exposure and subsequent precipitation of PTSD-like symptomatology 
has understandably focused on the neural pathways in the brain. How-
ever, our data indicate that exposure to a traumatic event exposure re-
sults in a significant multi-system metabolic reprogramming. Nearly all 
plasma metabolites analyzed through the targeted mitochondrial panel 
were significantly altered in stressed animals relative to naïve animals. 
Both stressed and PTSD-like animals were characterized by metabolic 
patterns of reduced mitochondrial energy metabolism and increased 
oxidative stress, and altered phospholipid metabolism, associated with 
changes to neurotransmitter balance, suggesting a possible role of 
cerebellar excitotoxicity in the pathophysiology of PTSD. 
It is notable that considerable overlap was observed between the 
altered metabolic pathways identified in the cerebellum, and those 
identified in the circulating plasma. Of the 11 metabolic pathways in the 
cerebellum significantly affected by exposure to trauma, 5 of those 
pathways were also significantly affected in the plasma. The use of 
biofluids such as plasma in the application of metabolomics in di-
agnostics is currently a major objective in the field of metabolomics 
research (Esterhuizen, van der Westhuizen, and Louw 2017). Our data 
suggest that metabolomic analysis of plasma metabolites may reveal 
biosignatures of impaired energetics in the brain secondary to trauma 
exposure, greatly increasing the utility of metabolomics in diagnosing 
and monitoring metabolic perturbations following trauma exposure and 
precipitation of PTSD-like symptomatology. 
It is also notable that while the cerebellar and plasma abundances of 
a large number of metabolites varied significantly in stressed animals 
relative to naïve animals, only a few metabolites were identified by LDA 
as clear discriminators of PTSD-like and PTSD resilient behavior. These 
data therefore suggest no single putative mitochondrial biomarker for 
PTSD-like behavior in mice. Unlike genetic defects in a single metabolic 
enzyme, it is unlikely that any single metabolite or pathway would serve 
as a biomarker for the complex psychopathology of PTSD. These data 
suggest that a more complex and nuanced metabolic biosignature of 
PTSD may ultimately be more useful for the diagnosis and treatment of 
PTSD. These data also highlight the importance of paradigms of PTSD- 
like symptomatology that discriminate PTSD-like and resilient ani-
mals, as treating all stressed animals in this paradigm as PTSD-like 
would have led to a profound misunderstanding of the metabolic pro-
file of PTSD-like individuals. Similarly, these data also highlight the 
challenges of utilizing paradigms that discriminate PTSD-like and 
resilient animals. The PTSD-induction paradigm utilized in this study 
precipitates PTSD-like symptomatology in ~15% of stressed animals, a 
rate comparable to that seen in humans. While this feature makes this 
paradigm particularly valuable as a pre-clinical model of PTSD, the 
small sample size of PTSD-like and resilient animals identified makes 
resolving differences between these groups challenging. Future studies 
therefore will aim to increase cohort size in order to increase the sample 
size of PTSD-like and resilient animals. Additional studies will also aim 
to use these data to predict the PTSD-like and resilient phenotypes, using 
discriminating metabolites identified in this study. It is also notable that 
recent investigations into metabolic shifts in the nucleus accumbens of 
mice exposed to chronic restraint stress identified alterations of several 
of the same metabolites identified in this study, though in opposing 
directions, including decreased abundance of Tau, Glu, Asp, Gln, PCho, 
and elevated GPC:Cho (Cherix et al., 2020). These data suggest that 
metabolic reprogramming involving pathways affecting these metabo-
lites, while strongly implicated in stress exposure and subsequent psy-
chopathology, may vary significantly between different brain areas in 
mice exposed to different stressors. These data strengthen the case for 
the importance of metabolomic analysis in both the diagnosis and 
treatment of psychopathologies, as well as the potential importance of 
treatments specific to individual psychiatric conditions. Ultimately, 
these data provide novel insights into the role of the cerebellum in the 
pathophysiology of both trauma exposure and PTSD-like behavior. 
These data also provide novel insight into the profound multi-system 
metabolic reprogramming associated with exposure to trauma and 
suggest several potential interventions both to increase trauma resil-
ience in high risk populations, including supplementation with BCAA’s 
and ketones. However, these findings remain preliminary, and further 
studies will be required to confirm that the metabolic shifts identified in 
this study are able to predict either PTSD-like behavior or susceptibility 
to PTSD-like behavior, and whether influencing these metabolic shifts 
through supplementation or therapeutic intervention can mediate 
PTSD-like symptomatology. 
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